4. Cardiovascular Support Techniques

Learning Objectives

• Differentiate vasopressors from inotropes and match specific agents to specific shock states
• Describe the sequence of basic life support and defibrillation in cardiac arrest
• Explain the indications, physiology, and limitations of mechanical circulatory support (IABP, Impella, VA-ECMO)
• Interpret core hemodynamic parameters (CVP, PAOP, CO, SVR) and use them to guide therapy
• Apply hemodynamic reasoning to distinguish cardiogenic, septic, hypovolemic, and obstructive shock
• Recognize common errors in vasopressor selection and hemodynamic interpretation

Quick Answer

Cardiovascular support techniques are the interventions critical care teams use to maintain adequate blood pressure, cardiac output, and organ perfusion when the heart or circulation fails. They range from basic life support (CPR, defibrillation) to pharmacologic support (vasopressors like norepinephrine, inotropes like dobutamine) to mechanical circulatory support (IABP, Impella, VA-ECMO). The right technique depends entirely on the underlying hemodynamic problem — a vasodilated septic patient needs a vasopressor, while a patient in cardiogenic shock with a "squeezed dry" heart needs an inotrope or mechanical pump instead. Choosing correctly requires understanding cardiac output, systemic vascular resistance, and how each shock type deranges them differently.

Overview: Why Cardiovascular Support Matters

Every organ in the body depends on a continuous supply of oxygenated blood. When the cardiovascular system fails — whether because the heart stops pumping, the vessels lose their tone, or the tank is empty — organs start to fail within minutes to hours. Cardiovascular support is the umbrella term for everything the ICU team does to buy time and restore perfusion while the underlying cause (myocardial infarction, sepsis, hemorrhage, tamponade) is treated.

The key mental model is a simple equation: Blood pressure = Cardiac Output × Systemic Vascular Resistance. Cardiac output itself depends on heart rate and stroke volume, and stroke volume depends on preload, afterload, and contractility. Nearly every intervention in this chapter is aimed at manipulating one of these variables. A drug or device that fixes the wrong variable can make a patient worse — this is the single most tested concept in cardiovascular critical care.

Basic Life Support and Defibrillation

When the heart stops generating a perfusing rhythm, the first priority is not a drug — it's compressions and, if indicated, electricity.

Cardiopulmonary Resuscitation (CPR)

CPR substitutes for the heart's pumping action using external chest compressions, supplemented by rescue breaths.

• Call for help / activate the emergency response system immediately
• Compress the lower half of the sternum at 100–120/min, to a depth of at least 5 cm, allowing full chest recoil between compressions
• Minimize interruptions — even brief pauses drop coronary perfusion pressure back to near zero
• Give a 30:2 compression-to-ventilation ratio if unprotected airway; continuous compressions with asynchronous breaths once intubated

High-quality compressions matter more than almost anything else in this section — coronary perfusion pressure takes 15–20 compressions to build back up after any interruption, which is why "minimize interruptions" is a repeated exam point.

Defibrillation and the AED

Defibrillation only works for "shockable" rhythms — ventricular fibrillation (VF) and pulseless ventricular tachycardia (pVT). It does nothing for asystole or pulseless electrical activity (PEA), which are treated with CPR, epinephrine, and finding the reversible cause (the classic "Hs and Ts").

1. Turn on the device and apply pads to bare chest (anterolateral or anteroposterior)
2. Let the device analyze the rhythm without touching the patient
3. If shock advised, clear the patient and deliver the shock
4. Resume CPR immediately after the shock — do not pause to check a pulse

Vasopressors and Inotropes

This is the section students most often get wrong, because the two drug classes are frequently used together but do fundamentally different jobs.

Vasopressors raise blood pressure primarily by increasing systemic vascular resistance (vasoconstriction). They are the first-line agents for distributive shock (septic, anaphylactic, neurogenic) where the vessels have lost tone and are inappropriately dilated.

Inotropes increase blood pressure and cardiac output by improving the heart's contractility. They are the go-to agents for cardiogenic shock, where the pump itself is failing and vasoconstriction would only add afterload the weak heart cannot overcome.

Drug	Class	Primary Receptor/Mechanism	Main Use
Norepinephrine	Vasopressor (some inotropy)	Alpha-1 (strong), Beta-1 (mild)	First-line for septic shock
Vasopressin	Vasopressor	V1 receptor	Add-on in septic shock refractory to norepinephrine
Phenylephrine	Pure vasopressor	Alpha-1 only	Hypotension with tachycardia where you don't want more heart rate
Epinephrine	Vasopressor + inotrope	Alpha-1, Beta-1, Beta-2	Cardiac arrest, anaphylaxis, second-line septic shock
Dobutamine	Inotrope	Beta-1 (mainly)	Cardiogenic shock, low-output heart failure
Milrinone	Inodilator	Phosphodiesterase-3 inhibitor	Cardiogenic shock, especially with high SVR/afterload

A frequent exam trap: dobutamine is a vasodilator as well as an inotrope (it can drop blood pressure), so it is not used alone in a hypotensive patient — it's often combined with a vasopressor, or reserved for patients who are already on pressor support.

Mechanical Circulatory Support

When drugs alone cannot maintain adequate perfusion, or when the underlying lesion is mechanical, devices can take over some of the heart's work.

Intra-Aortic Balloon Pump (IABP)

A balloon in the descending aorta inflates during diastole (augmenting coronary perfusion) and deflates just before systole (reducing the afterload the left ventricle must eject against). It provides modest hemodynamic support — useful as a bridge in cardiogenic shock or refractory angina, but it does not generate its own flow the way a pump does.

Percutaneous Ventricular Assist Devices (e.g., Impella)

A microaxial pump sits across the aortic valve and actively pulls blood from the left ventricle into the aorta, directly unloading the ventricle and increasing forward flow. Unlike the IABP, it provides true flow augmentation independent of the patient's own cardiac rhythm.

Venoarterial ECMO (VA-ECMO)

VA-ECMO drains venous blood, oxygenates it externally, and pumps it back into the arterial circulation, fully bypassing both the heart and lungs. It is reserved for the most severe, potentially reversible cardiac (with or without respiratory) failure — for example, refractory cardiogenic shock after massive MI, or fulminant myocarditis — because it is invasive, resource-intensive, and carries real risks (limb ischemia, bleeding, stroke). A key nuance: VA-ECMO increases left ventricular afterload, which can worsen pulmonary edema unless the left ventricle is also vented or unloaded (sometimes with a concurrent Impella — so-called "ECPELLA").

Hemodynamic Monitoring

You cannot titrate vasopressors and inotropes rationally without knowing what the numbers are actually doing.

Parameter	What It Reflects	Typical Change in Shock
Central venous pressure (CVP)	Right-heart filling pressure / preload	Low in hypovolemia, high in tamponade/PE/right heart failure
Pulmonary artery occlusion pressure (PAOP)	Left-heart filling pressure	Low in hypovolemia/sepsis, high in cardiogenic shock
Cardiac output (CO)	Pump function (HR × stroke volume)	Low in cardiogenic/hypovolemic shock, high in early sepsis
Systemic vascular resistance (SVR)	Vessel tone / afterload	Low in distributive shock, high in cardiogenic shock (compensatory)

Echocardiography (transthoracic or transesophageal) has largely supplanted routine pulmonary artery (Swan-Ganz) catheters for day-to-day assessment because it is noninvasive and gives immediate information on ejection fraction, wall motion, valve function, and pericardial fluid — but the Swan-Ganz catheter remains useful when continuous, real-time CO and PAOP trends are needed, such as in complex cardiogenic shock or when weaning mechanical support.

Arterial blood gas analysis complements hemodynamic numbers by revealing the metabolic consequence of poor perfusion — a rising lactate and worsening metabolic acidosis tell you the numbers on the monitor are not translating into adequate tissue oxygen delivery, regardless of what the blood pressure reads.

Clinical Vignettes

Cardiogenic shock after STEMI. A 55-year-old man with an inferior STEMI develops hypotension (82/54 mmHg), cool extremities, and pulmonary crackles. Echo shows an ejection fraction of 20%. This is cardiogenic shock: low CO with compensatory high SVR. Management prioritizes urgent revascularization (PCI), cautious inotrope support (dobutamine or milrinone), and consideration of temporary mechanical support (IABP or Impella) if the patient remains unstable — not aggressive fluids, which would worsen pulmonary edema.

Septic shock. A 72-year-old woman with pneumonia has a blood pressure of 80/50 mmHg despite 30 mL/kg of crystalloid. This is distributive shock: vasodilation dropping SVR while CO is often preserved or elevated. Norepinephrine is started as the first-line vasopressor, source control (antibiotics, drainage if applicable) is pursued in parallel, and vasopressin is added if norepinephrine requirements climb — this is the textbook example of matching the drug to the physiology rather than reflexively giving fluids or a single fixed pressor dose.

Key Terms

Term	Definition	Related Concept
Vasopressor	Drug that raises BP mainly by increasing systemic vascular resistance	Distributive shock, norepinephrine
Inotrope	Drug that raises cardiac output mainly by increasing myocardial contractility	Cardiogenic shock, dobutamine
Systemic vascular resistance (SVR)	Resistance the left ventricle must overcome to eject blood into the circulation	Afterload, shock classification
Cardiac output (CO)	Volume of blood the heart pumps per minute (HR × stroke volume)	Hemodynamic monitoring
IABP	Intra-Aortic Balloon Pump — counterpulsation device that augments coronary flow and reduces afterload	Cardiogenic shock, temporary mechanical support
Impella	Percutaneous microaxial pump that actively unloads the left ventricle	Mechanical circulatory support
VA-ECMO	Venoarterial ECMO — external circuit that bypasses both heart and lungs	Refractory cardiogenic shock
PAOP	Pulmonary Artery Occlusion Pressure — surrogate for left atrial/left ventricular filling pressure	Preload, Swan-Ganz catheter
ROSC	Return of Spontaneous Circulation — restoration of a perfusing rhythm after cardiac arrest	CPR, post-arrest care

Common Mistakes

Misconception: Norepinephrine and dobutamine are interchangeable "pressors" that can be used for any type of shock. Why it's wrong: Norepinephrine works mainly by vasoconstriction (raising SVR) and is designed for the vasodilated state of distributive shock. Dobutamine is an inotrope that can actually lower blood pressure through mild vasodilation while boosting contractility — giving it alone to a hypotensive, vasodilated septic patient can worsen hypotension. Correct understanding: Drug choice must match the hemodynamic problem: low SVR (distributive) needs a vasopressor; low contractility with adequate-to-high SVR (cardiogenic) needs an inotrope, often alongside a pressor if blood pressure is critically low.

Misconception: More fluid is always the right first move in any patient with low blood pressure. Why it's wrong: Fluid resuscitation is correct for hypovolemic and early septic shock, but in cardiogenic shock the ventricle is already overloaded and cannot handle additional preload — aggressive fluids will worsen pulmonary edema rather than raising blood pressure. In obstructive shock (tamponade, tension pneumothorax), the obstruction — not volume — is the problem. Correct understanding: Fluid responsiveness should be assessed (passive leg raise, IVC ultrasound, or a fluid challenge with reassessment) before assuming volume is the fix, especially when there are signs of volume overload or a known cardiac cause.

Misconception: The IABP and Impella devices generate significant cardiac output on their own, similar to VA-ECMO. Why it's wrong: The IABP does not pump blood at all — it only counterpulsates to modestly improve coronary perfusion and reduce afterload, contributing only a small fraction of cardiac output. Even the Impella, though it does generate real flow, provides less total circulatory support than VA-ECMO, which fully bypasses the heart and lungs. Correct understanding: Mechanical support exists on a spectrum of increasing support (and increasing invasiveness/risk): IABP < Impella < VA-ECMO. The choice depends on how much support the patient's native circulation still provides.

Comparison and Connections

Feature	Norepinephrine (vasopressor)	Dobutamine (inotrope)	IABP	Impella	VA-ECMO
Primary effect	↑ SVR	↑ Contractility	Modest afterload reduction, ↑ coronary flow	Direct LV unloading, ↑ flow	Full cardiopulmonary bypass
Generates own flow?	No	No	No	Yes (up to ~2.5–5 L/min)	Yes (full flow)
Best shock type	Distributive (septic)	Cardiogenic (low CO)	Cardiogenic (adjunct)	Cardiogenic (refractory)	Cardiogenic/mixed (refractory)
Invasiveness	Peripheral or central IV	Peripheral or central IV	Femoral arterial catheter	Femoral/axillary arterial catheter	Large-bore vascular cannulation
Key risk	Peripheral/digital ischemia at high doses	Tachyarrhythmia, hypotension	Limb ischemia, thrombocytopenia	Hemolysis, vascular injury	Limb ischemia, bleeding, LV distension

Practice Questions

Recall

1. Name three vasopressor or inotrope agents and classify each as a vasopressor, an inotrope, or both. Answer guidance: Norepinephrine (vasopressor with mild inotropy), phenylephrine (pure vasopressor), vasopressin (vasopressor), epinephrine (vasopressor + inotrope), dobutamine (inotrope), milrinone (inodilator/inotrope). Any three correctly classified.

2. What is the correct compression rate and depth for adult CPR, and what compression-to-ventilation ratio is used in an unprotected airway? Answer guidance: 100–120 compressions/min, at least 5 cm depth, with full chest recoil; 30:2 compression-to-ventilation ratio when the airway is not secured.

Understanding

3. Why is dobutamine rarely given alone to a hypotensive patient, and what is typically done instead? Answer guidance: Dobutamine's beta-2 mediated mild vasodilation can lower blood pressure further even as it improves contractility and cardiac output. In a hypotensive patient it is usually combined with a vasopressor like norepinephrine so contractility is improved without worsening blood pressure.

4. Explain why VA-ECMO can worsen pulmonary edema and what is done to address this. Answer guidance: VA-ECMO returns oxygenated blood retrograde into the arterial system, increasing the resistance (afterload) the native left ventricle must pump against. A weak, already-struggling LV may distend further, raising left atrial and pulmonary pressures and worsening pulmonary edema. This is addressed by LV venting or unloading, sometimes via a concurrent Impella device ("ECPELLA") or atrial septostomy.

Application

5. A patient in septic shock remains hypotensive on a maximal norepinephrine dose. What is the next appropriate step, and why? Answer guidance: Add vasopressin as a second-line agent. Vasopressin acts on V1 receptors, a different pathway from norepinephrine's alpha-1 mechanism, allowing additive vasoconstriction and often permitting a lower catecholamine dose, which reduces catecholamine-related tachyarrhythmia risk.

6. A patient with an anterior STEMI develops cardiogenic shock with a blood pressure of 78/50 mmHg and cool, mottled extremities. Fluids have already been given without improvement. What class of drug should be started, and what device might be considered if the patient does not stabilize? Answer guidance: Start an inotrope (dobutamine or milrinone) with or without a vasopressor to maintain minimum acceptable blood pressure while contractility improves; if refractory, escalate to temporary mechanical circulatory support such as an IABP or Impella, and urgent revascularization must proceed in parallel.

Analysis

7. Compare the physiologic problem, expected hemodynamic profile (CO and SVR), and first-line treatment in cardiogenic shock versus distributive (septic) shock. Answer guidance: Cardiogenic shock: pump failure, low CO, high SVR (compensatory vasoconstriction); treat with inotropes +/- mechanical support, avoid excess fluid. Distributive/septic shock: vasodilation, CO normal-to-high, low SVR; treat with fluids first, then norepinephrine as the primary vasopressor. The key contrast is that cardiogenic shock needs help pumping while septic shock needs help constricting.

8. A patient on VA-ECMO develops worsening pulmonary edema and a rising left atrial pressure despite adequate ECMO flow. Explain the mechanism and describe two ways the team could intervene. Answer guidance: The mechanism is LV afterload increase from retrograde arterial flow, causing the already-weak LV to distend (increased end-diastolic pressure) and back up pressure into the pulmonary circulation. Interventions include placing a concurrent Impella device to actively unload the LV ("ECPELLA"), performing an atrial septostomy to decompress the left atrium, or placing a surgical LV vent.

FAQ

Why do we use norepinephrine instead of dopamine as the first-line vasopressor in septic shock now? Older guidelines favored dopamine, but multiple large trials (notably the SOAP II trial) showed dopamine causes significantly more arrhythmias than norepinephrine without any survival benefit. Norepinephrine provides more predictable, potent alpha-1-mediated vasoconstriction with comparatively less arrhythmogenic beta-1 stimulation, which is why it is now the universally recommended first-line vasopressor in septic shock.

Is epinephrine a vasopressor or an inotrope? Both. At lower doses beta effects (increased contractility and heart rate) predominate; at higher doses alpha-mediated vasoconstriction becomes more prominent. This dual action is exactly why it is the drug of choice in cardiac arrest (needs both vasoconstriction to raise coronary perfusion pressure during CPR, and inotropic/chronotropic support once a rhythm returns) and in anaphylaxis (needs to reverse both vasodilation and bronchospasm).

What's the practical difference between the IABP and Impella that I should remember for exams? The IABP is a counterpulsation device — it inflates and deflates in time with the cardiac cycle to modestly help coronary flow and reduce afterload, but it does not itself pump blood forward. The Impella is a true axial-flow pump that sits across the aortic valve and physically moves blood from the LV to the aorta, providing meaningfully more circulatory support (measured in liters/minute) independent of the native heart rhythm.

Why doesn't VV-ECMO help a patient in cardiogenic shock? VV-ECMO only removes and re-oxygenates venous blood, returning it to the venous system — it improves gas exchange but does nothing to support the heart's pumping function or systemic blood pressure. A failing heart still has to eject that oxygenated blood on its own. Only VA-ECMO, which returns blood to the arterial system, provides circulatory (hemodynamic) support in addition to gas exchange.

How does the team decide when a patient is "too sick" for further escalation of cardiovascular support? This is guided by a combination of reversibility of the underlying cause, trajectory of organ function (renal, hepatic, neurologic), lactate clearance, and, critically, discussions with the patient's family about goals of care. Mechanical circulatory support is meant to be a bridge — to recovery, to transplant, or to a durable device — and ongoing escalation without a plausible bridge target raises important ethical questions that intensivists, cardiologists, and palliative care teams address together.

Quick Revision

• BP = CO × SVR; nearly every intervention targets one of these two variables
• Vasopressors (norepinephrine, vasopressin, phenylephrine) raise SVR — first-line for distributive/septic shock
• Inotropes (dobutamine, milrinone) raise contractility/CO — first-line for cardiogenic shock
• Epinephrine and norepinephrine both have dual vasopressor + inotrope action; pure agents are phenylephrine (pressor only) and dobutamine (inotrope only)
• CPR: 100–120 compressions/min, ≥5 cm depth, 30:2 ratio if airway unprotected, minimize interruptions
• Defibrillation only treats VF/pulseless VT — not asystole or PEA
• Cardiogenic shock: low CO, high SVR, cool extremities — avoid aggressive fluids
• Septic/distributive shock: normal-high CO, low SVR, warm extremities — fluids first, then norepinephrine
• Mechanical support escalation ladder: IABP (afterload reduction, no real flow) → Impella (true flow, LV unloading) → VA-ECMO (full cardiopulmonary bypass)
• VA-ECMO increases LV afterload and can worsen pulmonary edema — may need LV venting/Impella ("ECPELLA")
• Echo has largely replaced routine Swan-Ganz catheters, but PA catheters still help track CO/PAOP trends in complex cardiogenic shock
• Rising lactate signals inadequate tissue perfusion even if blood pressure numbers look acceptable

Related Topics

Prerequisites: Cardiovascular physiology (preload, afterload, contractility), shock physiology and classification, basic pharmacology of catecholamines

Related Topics: Intensive Care Unit Procedures, Hemodynamic Monitoring, Sepsis and Septic Shock Management, Acute Coronary Syndromes, Cardiac Arrhythmia Management

Next Topics: Advanced Cardiac Life Support (ACLS) algorithms, Post-Cardiac Arrest Care, Mechanical Ventilation in Cardiogenic Pulmonary Edema, Cardiogenic Shock Guideline-Directed Management